Evidence map›Paper›PMID 29731791›Full record

ArticleIranian journal of pathology2018

The Modulatory Effects of Vitamin D on the Expression of IL-12 and TGF-β in the Spinal Cord and Serum of Mice with Experimental Autoimmune Encephalomyelitis.

Rayhaneh Ahangar-Parvin, Marzieyeh Mohammadi-Kordkhayli, Sayyed Vahab Azizi, Maryam Nemati, Hossain Khorramdelazad, Zahra Taghipour, Zuhair Hassan, Sayyed Mohammad Moazzeni, Abdollah Jafarzadeh

Open access · goldAbstract read
In one paragraph

Article in Iranian journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Vitamin D in Neurological Diseases.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Rayhaneh Ahangar-ParvinMolecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Marzieyeh Mohammadi-KordkhayliDept. of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Sayyed Vahab AziziMolecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Maryam NematiDept. of Laboratory Sciences, Para-Medical School, Kerman University of Medical Sciences, Kerman, Iran.
Hossain KhorramdelazadMolecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Zahra TaghipourDept. of Histology, Medical School, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Zuhair HassanDept. of Immunology, Medical School, Tarbiat Moddares University, Tehran, Iran.
Sayyed Mohammad MoazzeniDept. of Immunology, Medical School, Tarbiat Moddares University, Tehran, Iran.
Abdollah JafarzadehMolecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Rafsanjan University of Medical Sciences · IRTarbiat Modares University · IRKerman University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

objectiveThe immunoregulatory effects of transforming growth factor (TGF)-βand interleukin-12 (IL-12) and immunomodulatory actions of vitamin D (VD) were reported in several studies. This study aims to evaluate VD effects on IL-12 and TGF-β expression in experimental autoimmune encephalomyelitis (EAE).

methodsEAE was induced in three groups of C57BL/6 mice by immunization with MOG and administered intra-peritoneally 200 ngVD, PBS or olive oil (OO) from day +3 to +30. One group was also considered as healthy control group. At day 31, cytokines expression in the spinal cord and their serum levels were determined using real time-PCR and ELISA, respectively.

resultsIL-12 gene expression and its serum levels in PBS-injected- or OO-administrated EAE groups were significantly higher than healthy group. IL-12 gene expression in EAE group treated with VD was significantly decreased compared to PBS-injected- or OO-administrated EAE groups (P<0.001 and P<0.02, respectively). Serum IL-12 levels were significantly reduced in VD-treated EAE mice compared to PBS-injected- or OO-administrated EAE groups (P<0.004 and P<0.05, respectively). No significant difference was observed between PBS-injected-EAE, OO-administrated EAE and healthy groups regarding the expression of TGF-β. In EAE mice treated with VD, TGF-β expression was significantly higher than healthy group and PBS-injected EAE mice (P<0.01 and P<0.04, respectively). VD-treated EAE group had also higher serum TGF-β levels than PBS-injected-, OO-administrated and healthy groups (P<0.05).

conclusionVD modulates the expression of IL-12 and TGF-β in spinal cord and serum of EAE mice.

Indexed as

Experimental Autoimmune EncephalomyelitisIL-12TGF-βVitamin D

Identifiers

PMID29731791
PMCPMC5929384
OpenAlexW2785920261

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.